2-Hydroxy
fatty acids (2-OHFAs) and 3-hydroxy fatty acids (3-OHFAs)
with the same carbon backbone are isomers, both of which are closely
related to diseases involving fatty acid oxidation disorder. However,
the comprehensive profiling of 2- and 3-OHFAs remains an ongoing challenge
due to their high structure similarity, few structure-informative
product ions, and limited availability of standards. Here, we developed
a new strategy to profile and identify 2- and 3-OHFAs according to
structure-dependent retention time prediction models using ultraperformance
liquid chromatography-tandem mass spectrometry (UPLC–MS/MS).
Both accurate MS and MS/MS spectra were collected for peak annotation
by comparison with an in-house database of theoretically possible
2- and 3-OHFAs. The structures were further confirmed by the validated
structure-dependent retention time prediction models, taking advantage
of the correlation between the retention time, carbon chain length
and number of double bonds, as well as the hydroxyl position-induced
isomeric retention time shift rule. With the use of this strategy,
18 2-OHFAs and 32 3-OHFAs were identified in the pooled plasma, of
which 7 2-OHFAs and 20 3-OHFAs were identified for the first time
in this work, furthering our understanding of OHFA metabolism. Subsequent
quantitation method was developed by scheduled multiple reaction monitoring
(MRM) and then applied to investigate the alteration of 2- and 3-OHFAs
in esophageal squamous cell carcinoma (ESCC) patients. Finally, a
potential biomarker panel consisting of six OHFAs with good diagnostic
performance was achieved. Our study provides a new strategy for isomer
identification and analysis, showing great potential for targeted
metabolomics in clinical biomarker discovery.